Pathologic basis of antibody-mediated organ transplant rejection: From pathogenesis to diagnosis

Current Opinion in Organ Transplantation

Volumn 18, Issue 4, 2013, Pages 478-485

  Joudeh, Amani ^a   Saliba, Khouloud Ahmad ^a   Topping, Kaila A ^a   Sis, Banu ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

antibody; complement; endothelium; rejection; transplantation

Indexed keywords

COMPLEMENT COMPONENT C4D; VON WILLEBRAND FACTOR;

ACUTE VASCULAR REJECTION; ANTIBODY MEDIATED REJECTION; CHRONIC GRAFT REJECTION; COMPLEMENT ACTIVATION; DISEASE CLASSIFICATION; DISEASE COURSE; GRAFT REJECTION; HUMAN; INFLAMMATION; KIDNEY INTERSTITIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR DIAGNOSIS; NATURAL KILLER CELL; PATHOGENESIS; REVIEW; THROMBOSIS;

COMPLEMENT SYSTEM PROTEINS; GRAFT REJECTION; HUMANS; ISOANTIBODIES; MOLECULAR DIAGNOSTIC TECHNIQUES; ORGAN TRANSPLANTATION;

EID: 84880920380     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283636ce6     Document Type: Review

References (64)

1. Jordan SC, Reinsmoen N, Lai CH, Vo A. Novel immunotherapeutic approaches to improve rates and outcomes of transplantation in sensitized renal allograft recipients. Discov Med 2012; 13:235-245
2. Stegall MD, Diwan T, Raghavaiah S, et al. Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant 2011; 11:2405-2413
3. Morath C, Beimler J, Opelz G, et al. An integrative approach for the transplantation of high-risk sensitized patients. Transplant 2010; 90:645-653
4. Gloor JM, Winters JL, Cornell LD, et al. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant 2010; 10:582-589
5. Sis B. Endothelial molecules decipher the mechanisms and functional pathways in antibody-mediated rejection. Hum Immunol 2012; 73:1218-1225
6. Jackson AM, Kuperman MB, Montgomery RA. Multiple hyperacute rejections in the absence of detectable complement activation in a patient with endothelial cell reactive antibody. Am J Transplant 2012; 12:1643-1649
7. Rodriguez ER, Skojec DV, Tan CD, et al. Antibody-mediated rejection in human cardiac allografts: Evaluation of immunoglobulins and complement activation products c4d and c3d as markers. Am J Transplant 2005; 5:2778-2785
8. Jin YP, Jindra PT, Gong KW, et al. Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection. Transplant 2005; 79 (Suppl 3):S19-S21
9. Regele H, Bohmig GA. Tissue injury and repair in allografts: Novel perspectives. Curr Opin Nephrol Hypertens 2003; 12:259-266
10. Minami K, Murata K, Lee CY, et al. C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats. Am J Transplant 2006; 6 (5 Pt 1):923-932
11. Burns JM, Cornell LD, Perry DK, et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 2008; 8:2684-2694
12. Valujskikh A, Heeger PS. Emerging roles of endothelial cells in transplant rejection. Curr Opin Immunol 2003; 15:493-498
13. Baldwin WM III, Kasper EK, Zachary AA, et al. Beyond C4d: Other complement-related diagnostic approaches to antibody-mediated rejection. Am J Transplant 2004; 4:311-318
14. Baldwin WMI, Larsen CP, Fairchild RL. Innate immune responses to transplants: A significant variable with cadaver donors. Immunity 2001; 14:369-376
15. Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005; 5:807-817
16. Morrell CN, Murata K, Swaim AM, et al. In vivo platelet-endothelial cell interactions in response to major histocompatibility complex alloantibody. Circ Res 2008; 102:777-785
17. Stegall MD, Chedid MF, Cornell LD. The role of complement in antibodymediated rejection in kidney transplantation. Nat Rev Nephrol 2012; 8:670-678
18. Colvin RB. Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18:1046-1056
19. Wiebe C, Gibson IW, Blydt-Hansen TD, et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant Am J Transplant 2012; 12:1157-1167
20. Loupy A, Suberbielle-Boissel C, Hill GS, et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donorspecific antibodies. Am J Transplant 2009; 9:2561-2570
21. Mengel M, Husain S, Hidalgo L, Sis B. Phenotypes of antibody-mediated rejection in organ transplants. Transpl Int 2012; 25:611-622
22. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8:753-760
23. Angelini A, Andersen CB, Bartoloni G, et al. A web-based pilot study of interpathologist reproducibility using the ISHLT 2004 working formulation for biopsy diagnosis of cardiac allograft rejection: The European experience. J Heart Lung Transplant 2011; 30:1214-1220
24. Sis B, Jhangri GS, Riopel J, et al. A new diagnostic algorithm for antibodymediated microcirculation inflammation in kidney transplants. Am J Transplant 2012; 12:1168-1179
25. Haas M, Rahman MH, Racusen LC, et al. C4d and C3d staining in biopsies of ABO-and HLA-incompatible renal allografts: Correlation with histologic findings. Am J Transplant 2006; 6:1829-1840
26. Sis B, Jhangri G, Bunnag S, et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9:2312-2323
27. Kissmeyer-Nielsen F, Olsen S, Peterson VP, Fjeldborg O. Hyperacute rejection of kidney allografts associated with preexisting humoral antibodies against donor cells. Lancet 1966; 2:662-665
28. Williams GM, Hume DM, Hudson RP, et al. Hyperacute renal-homograft rejection in man. N Engl J Med 1968; 279:611-618
29. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria: An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3:708-714
30. Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7:518-526
31. Magil AB, Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int 2003; 63:1888-1893
32. Fahim T, Bohmig GA, Exner M, et al. The cellular lesion of humoral rejection: Predominant recruitment of monocytes to peritubular and glomerular capillaries. Am J Transplant 2007; 7:385-393
33. Hidalgo LG, Sis B, Sellares J, et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: Evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant 2010; 10:1812-1822
34. Reed EF, Demetris AJ, Hammond E, et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006; 25:153-159
35. Loupy A, Cazes A, Guillemain R, et al. Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy. Am J Transplant 2011; 11:1478-1487
36. Drachenberg CB, Torrealba JR, Nankivell BJ, et al. Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema. Am J Transplant 2011; 11:1792-1802
37. Girnita AL, McCurry KR, Yousem SA, et al. Antibody-mediated rejection in lung transplantation: Case reports. Clin Transpl 2006; 508-510
38. Regele H, Bohmig GA,Habicht A, et al.Capillary deposition ofcomplement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13:2371-2380
39. Lerut E, Naesens M, Kuypers DR, et al. Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year. Transplant 2007; 83:1416-1422
40. Papadimitriou JC, Drachenberg CB, Munivenkatappa R, et al. Glomerular inflammation in renal allografts biopsies after the first year: Cell types and relationship with antibody-mediated rejection and graft outcome. Transplant 2010; 90:1478-1485
41. Papadimitriou JC, Drachenberg CB, Ramos E, et al. Antibody-mediated allograft rejection: Morphologic spectrum and serologic correlations in surveillance and for cause biopsies. Transplant 2013; 95:128-136
42. de KH, Willicombe M, Brookes P, et al. Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies. Am J Transplant 2013; 13:485-492
43. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9:2520-2531
44. Gaston RS, Cecka JM, Kasiske BL, et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplant 2010; 90:68-74
45. Husain S, Sis B. Advances in the understanding of transplant glomerulopathy. Am J Kidney Dis 2013; pii: S0272-6386(12)01513-2. doi: 10.1053/ j.ajkd.2012.10.026. [Epub ahead of print]
46. Wavamunno MD, O'Connell PJ, Vitalone M, et al. Transplant glomerulopathy: Ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant 2007; 7:2757-2768
47. Haas M, Mirocha J. Early ultrastructural changes in renal allografts: Correlation with antibody-mediated rejection and transplant glomerulopathy. Am J Transplant 2011; 11:2123-2131
48. Sis B, Mengel M, Haas M, et al. Banff '09 Meeting Report: Antibody mediated graft deterioration and implementation of banff working groups. Am J Transplant 2010; 10:464-471
49. Cornell LD, Gloor JM, Raghavaiah S, et al. Chronic antibody mediated histologic changes in positive-crossmatch kidney transplants (+XMKTx) receiving early C5 blockade. Am J Transplant 2012; 12 (Suppl 3):450
50. Loupy A, Hill GS, Suberbielle C, et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donorspecific antibodies (DSA). Am J Transplant 2011; 11:56-65
51. Mengel M, Sis B, Haas M, et al. Banff 2011 Meeting Report: New concepts in antibody-mediated rejection. Am J Transplant 2012; 12:563-570
52. Lefaucheur C, Loupy A, Vernerey D, et al. Antibody-mediated vascular rejection of kidney allografts: A population-based study. Lancet 2012
53. Sis B, Lategan B, Bagnasco S, et al. Significance of isolated vasculitis (v1) in kidney transplants: A multicenter observational study. Am J Transplant 2011; 11 (Suppl 2):58
54. Herzenberg AM, Gill JS, Djurdjev O, Magil AB. C4d deposition in acute rejection: An independent long-term prognostic factor. J Am Soc Nephrol 2002; 13:234-241
55. Sis B, Einecke G, Chang J, et al. Cluster analysis of lesions in kidney transplant biopsies: Microcirculation changes, tubulointerstitial inflammation, and scarring. Am J Transplant 2010; 10:421-430
56. Shimizu T, Ishida H, Shirakawa H, et al. Clinicopathological analysis of acute vascular rejection cases after renal transplantation. Clin Transplant 2010; 24 (Suppl 22):22-26
57. Moreso F, Carrera M, Goma M, et al. Early subclinical rejection as a risk factor for late chronic humoral rejection. Transplant 2012; 93:41-46
58. Gloor JM, Sethi S, Stegall MD, et al. Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Am J Transplant 2007; 7:2124-2132
59. Kobashigawa J, Crespo-Leiro MG, Ensminger SM, et al. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant 2011; 30:252-269
60. Wu GW, Kobashigawa JA, Fishbein MC, et al. Asymptomatic antibodymediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant 2009; 28:417-422
61. Kfoury AG, Snow GL, Budge D, et al. A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. J Heart Lung Transplant 2012; 31:46-51
62. Chih S, Tinckam KJ, Ross HJ. A survey of current practice for antibodymediated rejection in heart transplantation. Am J Transplant 2013; 13:1069-1074
63. O'Leary JG, Klintmalm GB. Impact of donor-specific antibodies on results of liver transplantation. Curr Opin Organ Transplant 2013; 18:279-284
64. Hubscher SG. Antibody-mediated rejection in the liver allograft. Curr Opin Organ Transplant 2012; 17:280-286